KR960703594A - 약제로서의 N-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도(Use Of N-Alkylated 1,4-Dihydropyridine Dicarboxylic Acid Esters as Medicaments) - Google Patents

약제로서의 N-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도(Use Of N-Alkylated 1,4-Dihydropyridine Dicarboxylic Acid Esters as Medicaments) Download PDF

Info

Publication number
KR960703594A
KR960703594A KR1019960700944A KR19960700944A KR960703594A KR 960703594 A KR960703594 A KR 960703594A KR 1019960700944 A KR1019960700944 A KR 1019960700944A KR 19960700944 A KR19960700944 A KR 19960700944A KR 960703594 A KR960703594 A KR 960703594A
Authority
KR
South Korea
Prior art keywords
compound
formula
carbon atoms
atherosclerosis
general formula
Prior art date
Application number
KR1019960700944A
Other languages
English (en)
Korean (ko)
Inventor
지그프리트 자이스
디이터 노이저
요한스-피터 스타쉬
지그프리트 골드만
Original Assignee
클라우스 로이터, 귄터 슈마허
바이엘 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클라우스 로이터, 귄터 슈마허, 바이엘 악티엔게젤샤프트 filed Critical 클라우스 로이터, 귄터 슈마허
Publication of KR960703594A publication Critical patent/KR960703594A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019960700944A 1993-08-27 1994-08-16 약제로서의 N-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도(Use Of N-Alkylated 1,4-Dihydropyridine Dicarboxylic Acid Esters as Medicaments) KR960703594A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4328884A DE4328884A1 (de) 1993-08-27 1993-08-27 Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
DEP4328884.7 1993-08-27
PCT/EP1994/002723 WO1995005823A1 (de) 1993-08-27 1994-08-16 Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsäureestern als arzneimittel

Publications (1)

Publication Number Publication Date
KR960703594A true KR960703594A (ko) 1996-08-31

Family

ID=6496196

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960700944A KR960703594A (ko) 1993-08-27 1994-08-16 약제로서의 N-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도(Use Of N-Alkylated 1,4-Dihydropyridine Dicarboxylic Acid Esters as Medicaments)

Country Status (13)

Country Link
EP (1) EP0714301A1 (no)
JP (1) JPH09501923A (no)
KR (1) KR960703594A (no)
CN (1) CN1129906A (no)
AU (1) AU7613594A (no)
BG (1) BG100367A (no)
CA (1) CA2170285A1 (no)
CZ (1) CZ43896A3 (no)
DE (1) DE4328884A1 (no)
HU (1) HUT75302A (no)
NO (1) NO960777L (no)
PL (1) PL313116A1 (no)
WO (1) WO1995005823A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741694C2 (de) * 1997-09-18 2002-10-31 Schering Ag Verwendung von Komplexen, deren Ligand ein Bis-Amin-Oxim-Derivat oder ein N¶2¶S¶2¶-Derivat und deren Zentralatom ein Radionuklid ist
CA2470813A1 (en) 2001-12-20 2003-07-03 Bayer Healthcare Ag 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2012342226B2 (en) * 2011-11-24 2017-09-28 Richter Gedeon Nyrt. 1,4- dihydropyridine derivatives with Hsp modulating activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
EP0169009A3 (en) * 1984-07-17 1988-08-31 FISONS plc Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
BG100367A (en) 1996-07-31
CZ43896A3 (en) 1996-05-15
NO960777L (no) 1996-04-10
CA2170285A1 (en) 1995-03-02
DE4328884A1 (de) 1995-03-02
NO960777D0 (no) 1996-02-26
EP0714301A1 (de) 1996-06-05
PL313116A1 (en) 1996-06-10
HUT75302A (en) 1997-05-28
JPH09501923A (ja) 1997-02-25
AU7613594A (en) 1995-03-21
CN1129906A (zh) 1996-08-28
HU9600472D0 (en) 1996-04-29
WO1995005823A1 (de) 1995-03-02

Similar Documents

Publication Publication Date Title
KR960703585A (ko) 재발협착증의 억제 방법(Method to inhibit restenosis)
RU99114020A (ru) Композиции и способы лечения или предупреждения воспалительных заболеваний
AU7476894A (en) Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
RU2004126705A (ru) Композиции и способы лечения или предупреждения воспалительных заболеваний
PH30120A (en) Stable pharmaceutical composition of fumagillol derivatives
DE69032414D1 (de) Diphenylmethane derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
MX9207224A (es) Apolipoproteina.
WO1999047497A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
KR930700450A (ko) 항미생물성 퀴놀론 티오우레아
WO1999012532A3 (en) Piperidine derivatives against malaria
JPS57185275A (en) Tetrahydro-dum-4 and tetrahydro-isodum-4 and their derivatives
KR960013370A (ko) 트리글리세리드 과다 방지 조성물
KR950700255A (ko) 피리딘카르복시이미드아미드 화합물 및 그 용도(pyridinecarboximidamide compounds and the use thereof)
KR950704314A (ko) 1,8-나프티리딘-2-온 유도체 및 그 사용 방법(1,8-naphthyridin-2-one derivative and use thereof)
KR950016727A (ko) 트롬보모듈린 발현을 증가시키는 방법
NO20014119L (no) Medikament inneholdende et sulfopyranosylacylglycerolderivat
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
KR960703594A (ko) 약제로서의 N-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도(Use Of N-Alkylated 1,4-Dihydropyridine Dicarboxylic Acid Esters as Medicaments)
KR940021064A (ko) 프레그네인 유도체의 사용 방법
RU98100111A (ru) Активирующая остеогенез фармацевтическая композиция
KR960703593A (ko) (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine)
MD960294A (ro) Procedeu de prevenire a stenozei pereţilor tubulari ai animalului, procedeu de prevenire a restenozei arteriale la om; utilizarea acidului hialuronic şi a formelor lui pentru prevenirea restenozei arteriale; compoziţie farmaceutică pe bază de acid hialuronic, de săruri, fragmente şi subunităţi ale acestuia
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
KR900014339A (ko) 헤테로시클릭 화합물, 그의 제조방법, 이를 함유하는 제약 조성물 및 의약으로서의 용도
KR950701636A (ko) 피리도티아진초산 화합물, 그의 제조방법 및 그의 용도(pyridothiazineacetic acid compound, process for producing the same, and use thereof]

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid